Kite accused of infringing Juno’s cancer immunotherapy

Juno Therapeutics and the Sloan Kettering Institute for Cancer Research have entered a second round of litigation against Kite, a company which specialises in cancer immunotherapy treatments.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

Gilead fails to overturn $752m BMS patent verdict

2 April 2020 A court has rejected Gilead’s attempt to overturn a $752 million verdict in a patent dispute with BMS’ Juno Therapeutics over CAR-T therapies.

Americas

Kite teams up with Sangamo to treat cancer

26 February 2018 Kite Pharma has entered into a collaboration with Sangamo Therapeutics that will see the companies develop next-generation engineered cell therapies to treat cancer.

Americas

Life sciences companies face off over ‘Juno’ trademark

26 July 2017 Clinical-stage biotech company Juno Therapeutics has not taken kindly to another business using its name.

More on this story

Biotechnology

Gilead fails to overturn $752m BMS patent verdict

2 April 2020 A court has rejected Gilead’s attempt to overturn a $752 million verdict in a patent dispute with BMS’ Juno Therapeutics over CAR-T therapies.

Americas

Kite teams up with Sangamo to treat cancer

26 February 2018 Kite Pharma has entered into a collaboration with Sangamo Therapeutics that will see the companies develop next-generation engineered cell therapies to treat cancer.

Americas

Life sciences companies face off over ‘Juno’ trademark

26 July 2017 Clinical-stage biotech company Juno Therapeutics has not taken kindly to another business using its name.

More on this story

Biotechnology

Gilead fails to overturn $752m BMS patent verdict

2 April 2020 A court has rejected Gilead’s attempt to overturn a $752 million verdict in a patent dispute with BMS’ Juno Therapeutics over CAR-T therapies.

Americas

Kite teams up with Sangamo to treat cancer

26 February 2018 Kite Pharma has entered into a collaboration with Sangamo Therapeutics that will see the companies develop next-generation engineered cell therapies to treat cancer.

Americas

Life sciences companies face off over ‘Juno’ trademark

26 July 2017 Clinical-stage biotech company Juno Therapeutics has not taken kindly to another business using its name.